| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/01/1995 | WO1995014776A1 PROTEIN TYROSINE KINASES NAMED Rse |
| 06/01/1995 | WO1995014775A1 Translational enhancer dna |
| 06/01/1995 | WO1995014774A2 Toxicity-resistant molasses gene, related products and use thereof for the analysis and enhancement of microorganisms and molasses |
| 06/01/1995 | WO1995014773A1 New transcription factor mutants and use thereof |
| 06/01/1995 | WO1995014772A1 Gene signature |
| 06/01/1995 | WO1995014769A1 TRANSGENIC MOUSE PREPARED USING YEAST ARTIFICIAL CHROMOSOMES (YACs) AND HOMOLOGOUS RECOMBINATION |
| 06/01/1995 | WO1995014714A1 Novel integrin-binding peptides |
| 06/01/1995 | WO1995014713A2 Abundant extracellular products and methods for their production and use |
| 06/01/1995 | WO1995014712A1 Streptococcus pneumoniae hemin/hemoglobin-binding antigens |
| 06/01/1995 | WO1995014711A1 Cell adhesion molecules and detecting adherence |
| 06/01/1995 | WO1995014708A1 Nucleic acid analogs with a chelating functionality |
| 06/01/1995 | WO1995014706A1 Pna-dna-pna chimeric macromolecules |
| 06/01/1995 | WO1995014487A1 Treatment of viral disease with cd40l peptide |
| 06/01/1995 | WO1995014436A1 A retrograde high frequency tissue splitter |
| 06/01/1995 | WO1995014377A2 Sepsis model |
| 06/01/1995 | WO1995007353A3 Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
| 06/01/1995 | WO1995006732A3 Bacterial exported proteins and acellular vaccines based thereon |
| 06/01/1995 | WO1995005471A3 Method for stable transformation of plants |
| 06/01/1995 | WO1995002058A3 Bacillus thuringiensis transposon tn5401 and its use in a site-specific recombination system for bacillus thuringiensis strain development |
| 06/01/1995 | WO1994026903A3 Human influenza virus peptides binding hla-i molecule |
| 06/01/1995 | WO1994025598A3 Methods and compositions for salmonella-based vaccines |
| 06/01/1995 | WO1994025594A3 Cloning, expression and vaccine composition corresponding to a peptide antigen of toxoplasma gondii |
| 06/01/1995 | DE4340798A1 New thrombin inhibitory proteins from saliva of blood sucking insects |
| 06/01/1995 | CA2177388A1 Design of drugs involving receptor-ligand-dna interactions |
| 06/01/1995 | CA2177356A1 Methods for diagnosing early lyme disease |
| 06/01/1995 | CA2177074A1 P53-binding polypeptides and polynucleotides encoding same |
| 06/01/1995 | CA2177070A1 Novel integrin-binding peptides |
| 06/01/1995 | CA2175250A1 Sepsis model |
| 06/01/1995 | CA2174863A1 Translational enhancer dna |
| 06/01/1995 | CA2153480A1 Gene signature |
| 05/31/1995 | EP0655626A1 Diagnostic assays for Alzheimer's disease |
| 05/31/1995 | EP0655503A1 Process for producing human serum albumin |
| 05/31/1995 | EP0655501A1 HIV-2 virus variants |
| 05/31/1995 | EP0655500A1 Allergenic polypeptide from Japanese cedar pollen and dna encoding it |
| 05/31/1995 | EP0655499A1 A novel gene encoding phytolacca antiviral protein |
| 05/31/1995 | EP0655498A1 RNA polymerase II transcription factor |
| 05/31/1995 | EP0655463A1 Cyclic hexapeptides having endothelin antagonistic activity |
| 05/31/1995 | EP0655462A1 Linear adhesion inhibitors |
| 05/31/1995 | EP0655461A1 Cyclic amino acid derivatives having ACE and NEP inhibiting activity |
| 05/31/1995 | EP0655252A1 Agent for suppressing the motor activity of gastrointestinal tracts |
| 05/31/1995 | EP0655251A1 Pharmaceutical composition for preventing or treating |
| 05/31/1995 | EP0655162A1 Compositions of bacteriorhodopsin variants with increased memory time and their use |
| 05/31/1995 | EP0655072A1 Equine herpesvirus glycoproteins |
| 05/31/1995 | EP0654968A1 Anti-microbial composition |
| 05/31/1995 | EP0557270B1 Cationized antibodies for delivery through the blood-brain barrier |
| 05/31/1995 | EP0553281B1 Preparation and characterization of liposomal formulations of tumor necrosis factor |
| 05/31/1995 | EP0375724B1 Biologically active bactericidal/permeability-increasing protein fragments |
| 05/31/1995 | EP0372019B1 RHOPTRY MEMBRANE ANTIGEN OF $i(PLASMODIUM FALCIPARUM) |
| 05/31/1995 | EP0329778B1 Molecular decoyants and methods of use thereof |
| 05/30/1995 | US5420264 Non-human primate CD4 polypeptides, human CD4 molecules capable of glycosylation, fragments thereof, fusion proteins thereof, genetic sequences thereof, and the use thereof |
| 05/30/1995 | US5420263 Amplification of human MDM2 gene in human tumors |
| 05/30/1995 | US5420252 For treatment of thrombotic disorders |
| 05/30/1995 | US5420250 Phase transfer process for producing native plasma protein concentrates |
| 05/30/1995 | US5420249 Incubation of proteins and separation |
| 05/30/1995 | US5420248 Acid soluble proteins |
| 05/30/1995 | US5420247 Genetic engineering and expression vectors |
| 05/30/1995 | US5420245 Tetrapeptide-based inhibitors of farnesyl transferase |
| 05/30/1995 | US5420244 Methods and compositions for diagnosing HTLV-I associated myelopathy and adult T-cell leukemia |
| 05/30/1995 | US5420243 Transforming growth factor |
| 05/30/1995 | US5420242 Production of human parathyroid hormone from microorganisms |
| 05/30/1995 | US5420113 [Leu13]motilin, DNAs coding for same and methods for producing same |
| 05/30/1995 | US5420110 Compositions and methods for inhibiting elastase |
| 05/30/1995 | US5420109 Cytokine restraining agents |
| 05/30/1995 | US5420105 Polymeric carriers for non-covalent drug conjugation |
| 05/30/1995 | US5420034 Seed-specific transcriptional regulation |
| 05/30/1995 | US5420031 Gypsy moth virus with enhanced polyhedra production stability |
| 05/30/1995 | US5420030 Molecular clones of HIV-1 viral strains MN-ST1 and BA-L and uses thereof |
| 05/30/1995 | US5420028 Truncated human cholesterol 7α-hydroxylase, method of production and use thereof |
| 05/30/1995 | US5420026 Self-assembling replication defective hybrid virus particles |
| 05/30/1995 | US5420020 Method and means for microbial polypeptide expression |
| 05/30/1995 | US5420019 Stable bactericidal/permeability-increasing protein muteins |
| 05/30/1995 | US5420014 Rapid in vitro test for helicobacter pylori using saliva |
| 05/30/1995 | US5420012 Method for the detection of reactive conditions |
| 05/30/1995 | US5419907 Pathogenic porcine respiratory coronavirus |
| 05/30/1995 | US5419899 Purified, reduced recombinant interleukin-2 compositions |
| 05/30/1995 | CA2050303C Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
| 05/30/1995 | CA1335722C Polyethylene glycol derivatives, modified peptides and production thereof |
| 05/30/1995 | CA1335720C Detection of necrotic malignant tissue and associated therapy |
| 05/30/1995 | CA1335717C Human granulocyte-macrophage colony stimulating factor and muteins thereof |
| 05/26/1995 | WO1995014233A2 Method of identifying hdm-2-specific antibodies |
| 05/26/1995 | WO1995014104A1 Method of identifying a substance capable of inducing bone formation |
| 05/26/1995 | WO1995014100A2 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 05/26/1995 | WO1995014097A1 Cloning and expression cassette, expression vectors and transformed bacteria comprising the r. capsulatus frup promoter, and applications |
| 05/26/1995 | WO1995014095A1 Endothelin-converting enzyme |
| 05/26/1995 | WO1995014093A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
| 05/26/1995 | WO1995014091A2 Compositions and methods for utilizing conditionally lethal genes |
| 05/26/1995 | WO1995014090A1 The human ep3 prostaglandin receptor |
| 05/26/1995 | WO1995014089A2 Cck-2, a receptor tyrosine kinase |
| 05/26/1995 | WO1995014088A1 Mck-10 (mammary carcinoma kinase), a receptor tyrosine kinase |
| 05/26/1995 | WO1995014085A2 A method for detection of alterations in the dna mismatch repair pathway |
| 05/26/1995 | WO1995014083A1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 05/26/1995 | WO1995014079A1 Myocardial grafts and cellular compositions useful for same |
| 05/26/1995 | WO1995014040A1 Monoclonal antibodies specific for human interleukin-5 |
| 05/26/1995 | WO1995014038A2 Purification of hemoglobin |
| 05/26/1995 | WO1995014035A1 Method for purification of a mixture of hydroxamate derivatized protein and native protein |
| 05/26/1995 | WO1995014034A1 Use of igf-bp for refolding of igf |
| 05/26/1995 | WO1995013831A1 Antibody to ocular and vaginal surface epithelium |
| 05/26/1995 | WO1995013828A1 Beneficial wound healing applications of calreticulin and other hyaluronan-associated proteins |
| 05/26/1995 | WO1995013824A1 Method of treating renal disease by administering igf-i and igfbp-3 |
| 05/26/1995 | WO1995013823A1 Method of treating neurological disorders |